-
-
-
-
-
-
-
Tetraphase Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights
-
-
-
-
-
-
-
Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual
-
-
-
-
-
-
-
Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases
-
-
-
-
-
-
-
After-Hours Stock Movers 01/02: (TRVN) (TTPH) Higher; (MGI) (ATRA) (HHC) Lower (more...)
-
15,422 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

